Avantax Advisory Services’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.34M Buy
49,719
+7,103
+17% +$763K 0.03% 433
2025
Q1
$4.3M Buy
42,616
+6,200
+17% +$625K 0.03% 464
2024
Q4
$3.25M Buy
36,416
+7,282
+25% +$650K 0.02% 531
2024
Q3
$2.44M Sell
29,134
-3,714
-11% -$311K 0.02% 608
2024
Q2
$2.53M Buy
32,848
+17,583
+115% +$1.35M 0.02% 580
2024
Q1
$1.05M Buy
15,265
+129
+0.9% +$8.84K 0.01% 728
2023
Q4
$875K Sell
15,136
-830
-5% -$48K 0.01% 762
2023
Q3
$843K Sell
15,966
-3,797
-19% -$200K 0.01% 749
2023
Q2
$1.07M Buy
19,763
+1,201
+6% +$65K 0.01% 657
2023
Q1
$929K Buy
18,562
+118
+0.6% +$5.9K 0.01% 684
2022
Q4
$853K Buy
18,444
+2,803
+18% +$130K 0.01% 682
2022
Q3
$606K Buy
15,641
+2,490
+19% +$96.5K 0.01% 699
2022
Q2
$490K Buy
13,151
+323
+3% +$12K 0.01% 789
2022
Q1
$567K Sell
12,828
-1,949
-13% -$86.1K 0.01% 741
2021
Q4
$628K Buy
14,777
+31
+0.2% +$1.32K 0.01% 682
2021
Q3
$645K Buy
14,746
+722
+5% +$31.6K 0.01% 622
2021
Q2
$601K Buy
14,024
+196
+1% +$8.4K 0.01% 635
2021
Q1
$538K Buy
13,828
+371
+3% +$14.4K 0.01% 597
2020
Q4
$484K Sell
13,457
-3,437
-20% -$124K 0.01% 565
2020
Q3
$649K Buy
16,894
+2,454
+17% +$94.3K 0.01% 705
2020
Q2
$508K Buy
14,440
+1,929
+15% +$67.9K 0.01% 479
2020
Q1
$411K Buy
12,511
+5,638
+82% +$185K 0.01% 485
2019
Q4
$312K Buy
+6,873
New +$312K 0.01% 613
2019
Q3
Sell
-5,330
Closed -$229K 573
2019
Q2
$229K Buy
+5,330
New +$229K 0.01% 453